Synairgen plc (LON:SNG – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 5.02 ($0.07) and traded as low as GBX 4.30 ($0.06). Synairgen shares last traded at GBX 4.62 ($0.06), with a volume of 63,603 shares.
Synairgen Stock Down 2.5 %
The firm’s 50-day moving average is GBX 3.95 and its two-hundred day moving average is GBX 5.02. The company has a debt-to-equity ratio of 0.09, a quick ratio of 6.35 and a current ratio of 6.77. The stock has a market cap of £9.06 million, a P/E ratio of -150.00 and a beta of -2.23.
Synairgen Company Profile
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Featured Articles
- Five stocks we like better than Synairgen
- There Are Different Types of Stock To Invest In
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What is a Death Cross in Stocks?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- How to Read Stock Charts for Beginners
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
